A cost analysis suggests that the use of probiotics could have a significant impact on eu health systems, potentially saving over €10 billion per year. However, it is reported that a regulatory gap may hinder the realization of these potential savings. The current rules governing probiotics may be outdated, prompting questions about their suitability in the present era.